TFFP - TFF Pharmaceuticals' (TFFP) CEO Glenn Mattes on Q1 2021 Results - Earnings Call Transcript
TFF Pharmaceuticals Inc. (TFFP) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Paul Sagan – Investor Relations Glenn Mattes – President, Chief Executive Officer and Director Dale Christensen – Director-Clinical Development Kirk Coleman – Chief Financial Officer Bill Williams – Professor, University of Texas, Austin Chris Cano – Chief Operating Officer and Head-Business Development Conference Call Participants Jonathan Aschoff – ROTH Capital Partners Daniel Carlson – TW Research Group Ram Selvaraju – H.C. Wainwright Bill Morrison – National Securities Presentation Operator Thank you for standing by. Welcome the TFF Pharmaceuticals Inc. First Quarter 2021 Financial and Business Results Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] Now I like to introduce your host for today’s program Paul Sagan, Investor Relations. Please go-ahead sir. Paul Sagan Thank you, operator. Hello everyone and welcome to TFF Pharmaceuticals’ first quarter 2021 financial
For further details see:
TFF Pharmaceuticals' (TFFP) CEO Glenn Mattes on Q1 2021 Results - Earnings Call Transcript